help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2007-1296
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Makras, P.
Right arrow Articles by Papapoulos, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Makras, P.
Right arrow Articles by Papapoulos, S. E.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Calcium and Bone Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 4 1386-1389
Copyright © 2008 by The Endocrine Society


BRIEF REPORT

Normal Growth and Muscle Dysfunction in X-Linked Hypophosphatemic Rickets Associated with a Novel Mutation in the PHEX Gene

Polyzois Makras, Neveen A. T. Hamdy, Sarina G. Kant and Socrates E. Papapoulos

Departments of Endocrinology and Metabolic Diseases (P.M., N.A.T.H., S.E.P.) and Clinical Genetics (S.G.K.), Leiden University Medical Center, 2333 ZA Leiden, The Netherlands

Address all correspondence and requests for reprints to: Socrates E. Papapoulos, M.D., Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. E-mail: m.v.Iken{at}lumc.nl.

Context: X-linked hypophosphatemic rickets (XLH) is characterized by hypophosphatemia and growth retardation. Early diagnosis and treatment improve growth.

Objective: Our objective was to describe long-term observations of a family with XLH due to a novel mutation of the PHEX gene with unusual clinical features, including normal growth.

Patients: The mother and her two sons were followed in the same institution for nearly 30 yr.

Results: The mother had hypophosphatemia and normal height (Z score, –0.6) without ever receiving any treatment. Her two sons achieved final heights of 183.7 cm (Z score, –0.01) and 182.7 cm (Z score, –0.18), respectively, despite late initiation of treatment with phosphate and low serum phosphate levels. In addition, they had reversible proximal myopathy that took about 7 yr to resolve in one of them. Direct sequencing of the PHEX gene revealed a new splice site mutation in intron 4 of the gene (IVS4+6T->C) resulting in skipping of exon 4.

Conclusions: Three members of a family with XLH due to a novel mutation of the PHEX gene had a normal growth pattern despite late diagnosis and treatment of the two boys and no treatment at all of their mother. The pathophysiological basis of this phenotype-genotype association warrants further investigation.




This article has been cited by other articles:


Home page
Annals of Clinical & Laboratory ScienceHome page
J. Kim, K. H. Yang, J. S. Nam, J. R. Choi, J. Song, M. Chang, and K.-A Lee
A Novel PHEX Mutation in a Korean Patient with Sporadic Hypophosphatemic Rickets
Ann. Clin. Lab. Sci., January 1, 2009; 39(2): 182 - 187.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society